Dover, Delaware
A biotech company that uses AI to decode small RNA (sRNA) isoforms and develop biomarker-guided precision oligonucleotide therapeutics, with a focus on identifying disease-associated isoforms and designing therapeutics to counteract their effects.
WITH CLARITAS SINCE
September 2022
KEY CLARITAS CONTACTS
John Chadwick
Managing Partner and CEO